The result demonstrated that ELOB was over expressed in all molecular subtypes of breast cancer (Fig. 1A) with the highest expression of ELOB in HR + /HER2- subtypes and the lowest in TNBC (P < 0.05, Fig. 1B). Here, ELOB is linked to breast cancer.